stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

MS Phase II Clinical Trial Launched Using Patient Stem Cells

Posted by devin@stemsave.com on Nov 4, 2018 9:44:00 AM

images-13

BrainStorm Cell Therapuetics is currently launching a Phase II clinical trial utilizing mesenchymal stem cells (MSCs) that are cultured to develop into neurological components able to treat progressive multiple sclerosis (MS). The proprietary technology called NurOwn uses a patient’s own (autologous) MSCs that are modified outside of the body and returned to repair and support neurons that are attacked in patients with MS. The stem cells are modified to produce growth factors, which support neurons and enhance differentiation and survival of neural cells.

Following a Phase I trial that determined the safety of the MSC treatment, the Phase II trial seeks to determine the optimal dosage of stem cells and is paving the way for a possible cure for MS.

Advances in stem cell based regenerative treatments are creating more effective treatment options for patients suffering from a wide variety of disease, trauma and injury. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.

 

The Future of Regenerative Medicine is Now™

To view the full article, click here

Topics: MS, multiple sclerosis treatment, multiple sclerosis, stem cell treatment, autologous stem cells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all